Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MYOS

MYOS RENS Technology (MYOS) Stock Price, News & Analysis

About MYOS RENS Technology Stock (NASDAQ:MYOS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.01
$11.40
52-Week Range
N/A
Volume
N/A
Average Volume
1.68 million shs
Market Capitalization
$16.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MYOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS RENS Technology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MYOS Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Bio-active Peptides Market Size Dynamics 2023-2029
See More Headlines

MYOS Stock Analysis - Frequently Asked Questions

MYOS RENS Technology Inc. (NASDAQ:MYOS) issued its earnings results on Tuesday, August, 6th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The firm earned $0.15 million during the quarter, compared to analyst estimates of $0.14 million. MYOS RENS Technology had a negative net margin of 277.82% and a negative trailing twelve-month return on equity of 166.68%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
8/06/2019
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MYOS
CIK
1402479
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.26 million
Net Margins
-277.82%
Pretax Margin
N/A
Return on Equity
-166.68%
Return on Assets
-104.95%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
3.78
Quick Ratio
1.94

Sales & Book Value

Annual Sales
$1.03 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
12,192,000
Free Float
N/A
Market Cap
$16.70 million
Optionable
Not Optionable
Beta
1.08
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:MYOS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners